MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation EV 2011-2026 | NVTA
EV Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 B | 3.39 B | 7.99 B | 2.03 B | 943 M | 403 M | 240 M | 143 M | 105 M | 47.3 M | 38.7 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.99 B | 38.7 M | 1.58 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
1.01 B | $ 8.9 | 0.39 % | $ 593 M |  USA |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 13.85 | 1.47 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
665 M | $ 26.04 | 0.81 % | $ 723 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
28.2 B | $ 68.33 | 2.99 % | $ 26.7 B | USA |
 |
Guardant Health
GH
|
15.2 B | $ 87.63 | 0.52 % | $ 11 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 154.73 | 1.82 % | $ 7.67 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 17.59 | 1.56 % | $ 937 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 168.86 | 2.41 % | $ 29 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | $ 103.89 | 0.04 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
502 M | $ 15.62 | 4.45 % | $ 472 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
142 M | $ 16.88 | -2.37 % | $ 2.19 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 100.35 | 2.81 % | $ 8.28 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.9 | 2.11 % | $ 94.1 K | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 195.77 | 2.29 % | $ 140 B | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.36 | 1.46 % | $ 1.07 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.4 | 2.95 % | $ 420 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 121.89 | 2.18 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 198.82 | -0.06 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
45.8 B | $ 113.9 | 1.85 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.12 | 0.9 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.32 | 2.25 % | $ 2.02 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 78.96 | 0.59 % | $ 5.33 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 452.34 | -0.29 % | $ 13 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 219.76 | 1.76 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
506 M | $ 114.23 | -0.58 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 46.61 | 3.55 % | $ 2.79 B | USA |
 |
National Research Corporation
NRC
|
432 M | $ 18.05 | 3.71 % | $ 404 M | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
5.53 B | $ 199.84 | 1.09 % | $ 19.7 B | USA |